FindTrial
Sign In

comparing anxiety level before surgery

A comparative study to see the efficacy of intranasal dexmeditomedine versus oral alprazolam as a premedication agent in morbid obese patients undergoing bariatric surgery - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2011/06/001786
Enrollment
40
Registered
2011-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Morbid obese patients

Interventions

Intervention1: Dexmedetomedine: Intanasal route 1 microgram/kg ideal body weight Duration of action 90 minutes Control Intervention1: Alprazolam tablet: Oral route 0.25 mg Duration of treatment 90 min

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. BMI 35 2. Hemodynamically stable

Exclusion criteria

Exclusion criteria: 1. Refusal to give consent 2. Known allergy to alpha2 agonists 3. Patients on psychotropic drugs 4. Recent cardiac events like coronary stenting, acute myocardial infarction 5. Mentally deranged patient

Design outcomes

Primary

MeasureTime frame
Sedation as per RAmsay sedation scoreTimepoint: after 45 minutes—

Secondary

MeasureTime frame
Heart rate ,Mean arterial pressure Saturation of oxygenTimepoint: BAseline After 45 minutes At tracheal intubation—

Countries

India

Contacts

Public ContactLakshmi jayaraman
lakjayaraman@gmail.com9811203658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026